New Strategies 64 paper spotlights need for cannabis product authentication, offers recommendations for federal oversight of cannabis supply chain

A new paper from the cannabis policy experts at Strategies 64 spotlights the need for effective cannabis product authentication and offers recommendations for future federal oversight of the cannabis supply chain.

The publication is an addendum to The One-plant Solution, a white paper released earlier this year that proposes a national unified cannabis policy and federal regulatory framework and identifies product authentication as a critical area of federal responsibility.

“Effective product authentication is fundamental to a successful federal cannabis regulatory system,” said Jordan Wellington, managing partner of Strategies 64. “Regulators need a reliable way to verify where products originated, how they moved through the supply chain, and whether they were produced and sold in compliance with applicable laws. Without it, product safety standards, youth access protections, marketing restrictions, and taxation are difficult to enforce, and regulated markets remain vulnerable to diversion and inversion.”

The new paper examines the two most commonly discussed approaches to cannabis product authentication: technology that monitors inventory and transactions throughout the supply chain, which many states are already using, and mandatory third-party distribution akin to the three-tier model applied to alcohol in the U.S.

Strategies 64 recommends leveraging technology and building on the inventory transparency systems already operating in state-regulated cannabis markets. State track-and-trace systems have more than a decade of real-world experience monitoring cannabis from cultivation through retail, and they can provide the foundation for a federal reporting framework that gives regulators visibility across state lines without requiring businesses to duplicate reporting or fundamentally restructure their operations.

The addendum also explores how modern data analysis and anomaly-detection tools could make that information substantially more useful to regulators. By analyzing inventory, transfer, pricing, testing, and sales data across markets, federal regulators could identify unusual activity and target enforcement toward potential diversion, inversion, tax avoidance, and other forms of noncompliance.

In contrast, the paper concludes that imposing a mandatory third-party distribution system modeled after alcohol would add costs, complexity, and market disruption without providing comparable regulatory benefits.

“The three-tier system was developed following the repeal of alcohol prohibition at a time when regulators lacked the technology to continuously monitor products through the supply chain,” Wellington said. “Today, inventory transparency technology can accomplish many of the same regulatory objectives more efficiently while providing regulators with significantly greater visibility. A modern product authentication framework can strengthen public health and safety, improve enforcement and tax compliance, and protect the integrity of regulated markets while minimizing unnecessary burdens on businesses.”

Read the full One-plant Solution white paper and the new Product Authentication addendum at one-plantsolution.org.

Weed Wonks Podcast: Mackenzie Slade of Cannabis Public Policy Consulting on Potency, Prices, and What Drives Consumers to the Illicit Market

In the latest episode of Weed Wonks, Strategies 64’s Jordan Wellington welcomes back Mackenzie Slade, CEO of Cannabis Public Policy Consulting, for a conversation about what makes a regulated cannabis market work. They explore Missouri’s successful and rapid rollout of adult-use legalization and the lessons it may offer other states.

Jordan and Mackenzie also discuss the ongoing challenge of balancing public health goals with a viable legal marketplace, including how policymakers approach taxation, product potency, labeling requirements, and competition with the illicit market.

Weed Wonks Podcast: Henry Crisler of 3MA and Attorney Slates Veazey on the Latest in Mississippi Cannabis Policy and What It Means for the Rest of the Industry

In this episode of Weed Wonks, Jordan Wellington sits down with Henry Crisler, executive director of the Mississippi Medical Marijuana Association (3MA), and Slates Veazey, partner and co-chair of the Cannabis Industry team at Bradley Arant Boult Cummings LLP, to unpack the latest policy, legal and business developments shaping the Magnolia State.

From recent legislative setbacks and growing industry consolidation to ongoing DEA inspections of Mississippi dispensaries, the conversation explores what these developments mean for operators in the state—and what the broader cannabis industry should be watching. Listen to the full episode for an inside look at Mississippi’s evolving cannabis landscape.

Denver Post includes S64’s Mason Tvert in list of “150 most notable people in Colorado history”

The Denver Post included Strategies 64 partner Mason Tvert in its list of the “150 most notable people in Colorado history,” which it published in celebration of Colorado’s 150th anniversary of statehood.

He and longtime colleague Brian Vicente were recognized for being “big, leading names behind the successful push to legalize recreational marijuana in Colorado.”

The Post noted:

The competition was fierce. We looked for those who had roots in Colorado that went beyond living here just a few months, had a profound impact on this state’s culture and history, helping the Centennial State become what it is today.

Some on the list are people whose achievements were of national, international or interstellar significance, so their inclusion is warranted even if their direct influence in Colorado was less marked.

NIST scales report highlights role for national standards in cannabis regulation

In late June, the National Institute of Standards and Technology (NIST) published a report examining the suitability of scales used to weigh cannabis products. As Marijuana Moment reports, the 31-page document aims to assist state marijuana officials in developing standards for scales used in marijuana sales.

At first glance, scale requirements may seem like a narrow weights-and-measures issue. In practice, they are exactly the type of technical regulatory question that determines whether cannabis markets function fairly and consistently. When products are sold by weight, scale accuracy affects consumers, licensed businesses, tax collection, and regulatory oversight.

The report does not prescribe specific rules for states to adopt. Instead, NIST explains that its purpose is to provide objective technical information to help regulators evaluate scale requirements for cannabis sales. This is the right role for federal agencies in a modern cannabis framework—provide expertise, support consistency, and help states regulate effectively. It is also a key recommendation in our white paper, The One-plant Solution, which calls for cannabis to be regulated as one plant through familiar federal and state channels, with product-specific standards that reflect the realities of the marketplace.

The NIST report offers a good example of how federal agencies can support state cannabis regulation without creating a one-size-fits-all system. State and local weights-and-measures officials are already responsible for enforcing scale requirements in legal cannabis markets. NIST can help those officials make more informed and consistent decisions.

This model aligns closely with the federalist approach recommended in The One-plant Solution, in which states continue serving as the primary regulators of cannabis activity within their borders, while the federal government supports those efforts where consistency is important.

Weights and measures is one of those areas. Scale requirements affect consumer confidence, competitive fairness, product authentication, and tax administration. If standards vary too widely or are not grounded in technical analysis, businesses and regulators can face unnecessary complexity.

The One-plant Solution white paper and additional related resources are available at one-plantsolution.org.

Regulate cannabis end products, not the source material

There is an emerging consensus that cannabis should be regulated based on the nature of the end products and not whether they were derived from “hemp” or “marijuana.” Those categories are legal distinctions, not botanical ones, and they have produced a fragmented regulatory system in which identical cannabinoid products can be subject to entirely different rules based solely on the THC concentration of the source plant.

A growing number of stakeholders recognize this approach is difficult to justify and becoming increasingly unworkable. It was the first point in a list of consensus points released earlier this year by a group of hemp and marijuana business leaders collaborating informally as the “Commission.” Specifically, it recommended:

Strategies 64 had the privilege of participating in the Commission, and the product-based approach it proposes is a central recommendation of our white paper, The One-plant Solution. (It is one of several areas in which the Commission and the paper are aligned, as we discussed earlier this year.)

By regulating finished products according to their composition, intended use, and safety profile, rather than the legal classification of the plant from which they were derived, federal policymakers can build a more coherent regulatory framework that better protects public health, provides greater certainty for businesses, and is considerably easier to administer and enforce.

Embrace existing pathways for most product types

Once cannabis is fully descheduled, federal regulation can move beyond the artificial hemp-marijuana divide and instead classify products according to their intended use and risk profile. Rather than creating separate regulatory systems for identical compounds based solely on where they originated, existing federal agencies can regulate cannabis products through pathways they already administer.

Cultivation

Cannabis cultivation should be regulated by the U.S. Department of Agriculture in a manner consistent with other agricultural commodities. Federal oversight can focus on areas where national consistency is important, including pesticide standards and inventory transparency to protect against diversion and inversion, while allowing state and local governments to regulate time, place, and manner of cultivation. This includes developing minimum security standards, identifying appropriate zoning and setback requirements, and addressing odor mitigation, among other things.

Industrial and agricultural products

Industrial and agricultural products like fiber, grain, hurd should also be regulated by USDA under the same agricultural framework that governs comparable non-consumable crops. These products comprise a genuinely different commercial activity than cannabinoid production for consumer products, and they present very different public health and safety risks. The regulatory environment should reflect this.

Consumable products

The Food and Drug Administration already classifies and regulates foods, dietary supplements, cosmetics, and pharmaceuticals based on well-established safety standards. Cannabis ingredients that satisfy those existing standards, such as hemp seed ingredients currently used in food, should follow those same regulatory pathways without any changes or special treatment.

Adult-restricted cannabis products

Some cannabis products would not meet the safety standards to fit within the existing FDA classifications. The One-plant Solution proposes creating an “adult-restricted cannabis products” category under a new product safety standard or exemption like those created for alcohol. This classification would recognize products that warrant additional safeguards while remaining appropriate for lawful adult consumers. For example, “adult-restricted products” would include those that contain intoxicating cannabinoids or levels of CBD that exceed dietary supplement safety standards. Popular products like cannabis flower and vaporizers also do not fit within existing FDA product categories, so this pathway would allow for targeted safety standards to allow for the safe sale of such products.

Adult-restricted cannabis products could be subject to additional restrictions such as age-gating, marketing limitations, product authentication, and taxation. This would be the only classification requiring novel regulations, and it should be jointly overseen by the FDA and the Alcohol and Tobacco Tax and Trade Bureau (TTB), which could leverage best practices from similarly exempted products. access. Federal oversight would focus on ensuring products are manufactured safely, remain within the regulated supply chain, and are sold only to adults, while leaving most regulatory activities currently associated with the marijuana market to state and local governments.

Moving forward

The artificial distinction between hemp and marijuana has outlived its usefulness. It has created unnecessary complexity for regulators, uncertainty for businesses, and inconsistent protections for consumers. Continuing to build federal policy around that distinction will only compound those problems as the marketplace continues to evolve.

Regulating products rather than source material offers a practical foundation for modernizing federal cannabis policy. By building on existing federal regulatory frameworks and tailoring oversight to the characteristics of finished products, policymakers can replace today’s fragmented system with one that is more coherent, enforceable, and protective of public health.

Both The One-plant Solution and the Commission see this as the logical starting point for creating a modern federal regulatory framework, and we hope consensus among stakeholders will continue to grow.

Weed Wonks Podcast: Public Health Researcher Alisa Padon on Responsible Cannabis Product Marketing

In the latest episode of Weed Wonks, Jordan Wellington sits down with Dr. Alisa Padon, Research Director at the Prevention Policy Group (PPG), for a thoughtful discussion on cannabis marketing and its role in protecting public health.

The conversation examines how cannabis can be marketed to adult consumers without appealing to youth, the influence of pop culture on public perceptions of cannabis use, and the types of advertising practices most likely to contribute to unhealthy consumption. Jordan and Dr. Padon also discuss the importance of balancing public health considerations with broader policy objectives as legal cannabis markets continue to evolve.

Listen to the full episode to hear their insights on responsible cannabis marketing and the future of cannabis policy.

Webinar: One Plant, One Framework – A Smarter Approach to Cannabis Regulation

Strategies 64’s Jordan Wellington recently participated in a webinar with S3 Collective exploring the future of cannabis regulation and the case for a unified, single-plant framework (The One-plant Solution).

During the discussion, Jordan examined how the current divide between hemp and marijuana has created regulatory challenges and highlighted how unified standards could improve product safety, consumer protections, and regulatory consistency. He also shared how these concepts are informing ongoing work at ASTM D37 and CANNRA’s External Stakeholders Summit.

Weed Wonks Podcast: Chuck Smith of Colorado Leads on Cannabis Consumer Trends and How to Advance the Industry While Also Prioritizing Public Safety

In our most recent podcast, Jordan Wellington spoke with Chuck Smith, CEO of Colorado Leads, about the challenges of protecting and advancing Colorado’s legal cannabis industry while maintaining a strong focus on public safety.

Their conversation explored the unique regulatory environment facing cannabis businesses, including why certain consumer trends that succeed in other industries have been slower to emerge in cannabis. They also took a closer look at the cannabis beverage market, discussing the economic and logistical challenges that continue to limit growth and the legislation considered this year in Colorado to address those barriers.

The discussion highlights the ongoing effort to balance innovation, consumer demand, and responsible regulation as the cannabis industry continues to evolve.

Back to top